Don't have a Account?
It's fast, free and easy to sign in with Facebook, Google, or Yahoo. Be connected on your terms - we won't share anything without your permission
| Connect with us
View the results of recent polls
Has the US Supreme Court delivered a win-win verdict in the Myriad vs ACLU BRCA gene patenting case?
Will the Ranbaxy controversy end the Indian pharma dominion in the US market?
Have Chinese scientists done the right thing by fusing human and avian flu strains to create new killer viruses?
Do you think women and men are equal achievers in the bioscience industry?
Are the R&D pipelines of multinational drug companies drying up?
Is point-of-care the hottest trend in medical devices?
Is Barack Obama's re-election a boon for the generics industry?
Will the new Indian biosimilars guidelines streamline the process for drug approvals?
Do you think Asian CROs will grow because of R&D cuts in the pharmaceutical companies of the West?
India allows compulsory licensing for Bayer's Nexavar. Does this raise a question about India's IP regime?
India's Union Budget 2014
Was the Pharma Industry neglected in the Country's UNION BUDGET 2014?
Subscribe to BioSpectrum Asia
Subscribe to BioSpectrum Asia digital mag at an attractive price of US $49.99 a year
(Includes all 24 regular & special issues @ fortnightly frequency)
BioSpectrum Asia Newsletters
Sign up for the daily news from Asia bioscience industry
Asia Life Science Services Resource Guide
Asia Life Science Services Resource Guide is the first-of-its-kind Resource Guide, focused on providing information that you need for outsourcing the drug discovery and manufacturing process to Asia.
Copyright © 2014 MM ACTIV. All rights reserved.
Reproduction in whole or in part in any form or medium without written permission is prohibited.
Send this article by email